Curatis Holding AG (CHIX:CURNZ) Momentum Rank : 9 (As of Sep. 22, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Curatis Holding AG Momentum Rank?

Curatis Holding AG has the Momentum Rank of 9.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Curatis Holding AG's Momentum Rank

For the Drug Manufacturers - Specialty & Generic subindustry, Curatis Holding AG's Momentum Rank, along with its competitors' market caps and Momentum Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curatis Holding AG's Momentum Rank Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curatis Holding AG's Momentum Rank distribution charts can be found below:

* The bar in red indicates where Curatis Holding AG's Momentum Rank falls into.

Curatis Holding AG Momentum Rank Related Terms

Thank you for viewing the detailed overview of Curatis Holding AG's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Curatis Holding AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (CHIX:CURNz) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

CURN:Switzerland

Address

Hochbergerstrasse 60C, Technologiepark Basel, Basel, CHE, 4057

Website

https://www.kinarus.com

Kinarus Therapeutics Holding AG In Liquidation Formerly Kinarus Therapeutics Holding AG is a clinical-stage pharmaceutical company focused on bringing novel treatments to patients suffering from viral, respiratory, and ophthalmic diseases. The company's therapeutic drug candidate, KIN001, consists of a clinical-stage p38 mitogen-activated protein kinase (p38 MAPK) inhibitor, in-licensed from Roche, combined with a marketed drug, together enabling an oral, long-term effective treatment for patients suffering from diseases with serious impact on quality of life.

Curatis Holding AG Headlines

No Headlines